Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Therapeutic Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global therapeutic vaccines market size reached US$ 25.63 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 49.89 Billion by 2027, exhibiting a growth rate (CAGR) of 11.40% during 2022-2027.

Therapeutic vaccines are a range of biological medications designed to stimulate or trigger the adaptive immune system to prevent disease-causing organisms and infections. They can be modified based on various applications and needs for treating different disorders, including cancer, human immunodeficiency virus (HIV) infections, and Alzheimer’s. Therapeutic vaccines aid in creating antibodies for protecting the body against pathogens, recognizing viruses or cancerous cells, reducing the viral set point in infected patients, and providing better clinical outcomes. Along with this, they are cost-effective, easy to use, and can treat late-stage diseases; thus, it is extensively used in clinical laboratories, hospitals, and vaccination centers for immunization. Currently, they are available in autoimmune, cancer, infectious and neurological disease vaccination types. 

Therapeutic Vaccines Market Trends:

The increasing prevalence of various chronic ailments and the growing need for effective biologic medications for specific and targeted responses are primarily driving the therapeutic vaccines market growth. In line with this, the implementation of numerous government initiatives promoting compulsory immunization of individuals during the COVID-19 pandemic and the ongoing funding in biopharmaceutical companies to develop viral recombinants are acting as another growth-inducing factors. Additionally, the extensive utilization of morphogenesis gene therapy with exosome-mediated delivery technology for the advent of patient-specific vaccines to deal with varying cancer types is impelling the market growth. This is further supported by the escalating uptake of genetic engineering, the availability of quick deployment vaccines, and the introduction of faster drug development solutions to improve medicine designs. Apart from this, rapid enhancements in the healthcare sector, fueling consumer awareness regarding the accessibility to several therapeutic drugs, and ongoing research and development (R&D) activities to enhance product effectiveness are creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global therapeutic vaccines market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, disease type, technology and distribution channel.

Breakup by Type:

  • Antigen Vaccines
  • Dendritic Cell Vaccine
  • DNA Vaccine
  • Tumor Cell Vaccines
     

Breakup by Disease Type:

  • Autoimmune Disease Vaccines
  • Addiction Vaccine
  • Neurological Disease Vaccine
  • Infectious Disease Vaccine
  • Others
     

Breakup by Technology:

  • Autologous Vaccines
  • Allogeneic Vaccine
     

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Agenus Inc., Argos Therapeutics Inc., Bavarian Nordic A/S, Cel-Sci Corporation, CSL Limited, Emergent Biosolutions Inc., GSK plc, Merck & Co. Inc., Pfizer Inc. and Sanofi S.A.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Type, Disease Type, Technology, Distribution Channel, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Agenus Inc., Argos Therapeutics Inc., Bavarian Nordic A/S, Cel-Sci Corporation, CSL Limited, Emergent Biosolutions Inc., GSK plc, Merck & Co. Inc., Pfizer Inc. and Sanofi S.A.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global therapeutic vaccines market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global therapeutic vaccines market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the disease type?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global therapeutic vaccines market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Therapeutic Vaccines Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Type
    6.1    Antigen Vaccines
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Dendritic Cell Vaccine
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    DNA Vaccine
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Tumor Cell Vaccines
        6.4.1 Market Trends
        6.4.2 Market Forecast
7    Market Breakup by Disease Type
    7.1    Autoimmune Disease Vaccines
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Addiction Vaccine
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Neurological Disease Vaccine
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Infectious Disease Vaccine
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Others
        7.5.1 Market Trends
        7.5.2 Market Forecast
8    Market Breakup by Technology
    8.1    Autologous Vaccines
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Allogeneic Vaccine
        8.2.1 Market Trends
        8.2.2 Market Forecast
9    Market Breakup by Distribution Channel
    9.1    Hospital Pharmacies
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Retail Pharmacies
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Online Pharmacies
        9.3.1 Market Trends
        9.3.2 Market Forecast
10   Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11    SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Price Analysis
15    Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Agenus Inc.
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
           15.3.1.3 Financials
           15.3.1.4 SWOT Analysis
        15.3.2    Argos Therapeutics Inc.
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
        15.3.3    Bavarian Nordic A/S
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
           15.3.3.3 Financials
        15.3.4    Cel-Sci Corporation
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
           15.3.4.3 Financials
           15.3.4.4 SWOT Analysis
        15.3.5    CSL Limited
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
           15.3.5.3 Financials
           15.3.5.4 SWOT Analysis
        15.3.6    Emergent Biosolutions Inc.
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
           15.3.6.3 Financials
           15.3.6.4 SWOT Analysis
        15.3.7    GSK plc
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
           15.3.7.3 Financials
           15.3.7.4 SWOT Analysis
        15.3.8    Merck & Co. Inc.
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
           15.3.8.3 Financials
           15.3.8.4 SWOT Analysis
        15.3.9    Pfizer Inc.
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
           15.3.9.3 Financials
           15.3.9.4 SWOT Analysis
        15.3.10    Sanofi S.A.
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio
           15.3.10.3 Financials
           15.3.10.4 SWOT Analysis

List of Figures

Figure 1: Global: Therapeutic Vaccines Market: Major Drivers and Challenges
Figure 2: Global: Therapeutic Vaccines Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Therapeutic Vaccines Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Therapeutic Vaccines Market: Breakup by Type (in %), 2021
Figure 5: Global: Therapeutic Vaccines Market: Breakup by Disease Type (in %), 2021
Figure 6: Global: Therapeutic Vaccines Market: Breakup by Technology (in %), 2021
Figure 7: Global: Therapeutic Vaccines Market: Breakup by Distribution Channel (in %), 2021
Figure 8: Global: Therapeutic Vaccines Market: Breakup by Region (in %), 2021
Figure 9: Global: Therapeutic Vaccines (Antigen Vaccines) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Therapeutic Vaccines (Antigen Vaccines) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Therapeutic Vaccines (Dendritic Cell Vaccine) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Therapeutic Vaccines (Dendritic Cell Vaccine) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Therapeutic Vaccines (DNA Vaccine) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Therapeutic Vaccines (DNA Vaccine) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Therapeutic Vaccines (Tumor Cell Vaccines) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Therapeutic Vaccines (Tumor Cell Vaccines) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Therapeutic Vaccines (Autoimmune Disease Vaccines) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Therapeutic Vaccines (Autoimmune Disease Vaccines) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Therapeutic Vaccines (Addiction Vaccine) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Therapeutic Vaccines (Addiction Vaccine) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Therapeutic Vaccines (Neurological Disease Vaccine) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Therapeutic Vaccines (Neurological Disease Vaccine) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Therapeutic Vaccines (Infectious Disease Vaccine) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Therapeutic Vaccines (Infectious Disease Vaccine) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Therapeutic Vaccines (Other Disease Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Therapeutic Vaccines (Other Disease Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Therapeutic Vaccines (Autologous Vaccines) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Therapeutic Vaccines (Autologous Vaccines) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Therapeutic Vaccines (Allogeneic Vaccine) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Therapeutic Vaccines (Allogeneic Vaccine) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Therapeutic Vaccines (Hospital Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Therapeutic Vaccines (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Therapeutic Vaccines (Retail Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Therapeutic Vaccines (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Therapeutic Vaccines (Online Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Therapeutic Vaccines (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: North America: Therapeutic Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: North America: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: United States: Therapeutic Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: United States: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Canada: Therapeutic Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Canada: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Asia-Pacific: Therapeutic Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Asia-Pacific: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: China: Therapeutic Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: China: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Japan: Therapeutic Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Japan: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: India: Therapeutic Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: India: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: South Korea: Therapeutic Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: South Korea: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Australia: Therapeutic Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Australia: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Indonesia: Therapeutic Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Indonesia: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Others: Therapeutic Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Others: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Europe: Therapeutic Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Europe: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Germany: Therapeutic Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Germany: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: France: Therapeutic Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: France: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: United Kingdom: Therapeutic Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: United Kingdom: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Italy: Therapeutic Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Italy: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Spain: Therapeutic Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Spain: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Russia: Therapeutic Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Russia: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Others: Therapeutic Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Others: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Latin America: Therapeutic Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Latin America: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Brazil: Therapeutic Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Brazil: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Mexico: Therapeutic Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Mexico: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Others: Therapeutic Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Others: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Middle East and Africa: Therapeutic Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: Middle East and Africa: Therapeutic Vaccines Market: Breakup by Country (in %), 2021
Figure 85: Middle East and Africa: Therapeutic Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 86: Global: Therapeutic Vaccines Industry: SWOT Analysis
Figure 87: Global: Therapeutic Vaccines Industry: Value Chain Analysis
Figure 88: Global: Therapeutic Vaccines Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Therapeutic Vaccines Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Therapeutic Vaccines Market Forecast: Breakup by Type (in Million US$), 2022-2027
Table 3: Global: Therapeutic Vaccines Market Forecast: Breakup by Disease Type (in Million US$), 2022-2027
Table 4: Global: Therapeutic Vaccines Market Forecast: Breakup by Technology (in Million US$), 2022-2027
Table 5: Global: Therapeutic Vaccines Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 6: Global: Therapeutic Vaccines Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Therapeutic Vaccines Market: Competitive Structure
Table 8: Global: Therapeutic Vaccines Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links

4